RT Journal Article
SR Electronic
T1 Face Coverings and Respiratory Tract Droplet Dispersion
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.08.11.20145086
DO 10.1101/2020.08.11.20145086
A1 Bandiera, Lucia
A1 Pavar, Geethanjali
A1 Pisetta, Gabriele
A1 Otomo, Shuji
A1 Mangano, Enzo
A1 Seckl, Jonathan R.
A1 Digard, Paul
A1 Molinari, Emanuela
A1 Menolascina, Filippo
A1 Viola, Ignazio Maria
YR 2020
UL http://medrxiv.org/content/early/2020/08/14/2020.08.11.20145086.abstract
AB Respiratory droplets are the primary transmission route for SARS-CoV-2. Evidence suggests that virus transmission can be reduced by face coverings, but robust evidence for how mask usage might affect safe distancing parameters is lacking. Accordingly, we investigate the effectiveness of surgical masks and single-layer cotton masks on mitigating dispersion of large respiratory droplets (i.e. non aerosol). We tested a manikin ejecting fluorescent droplets and human volunteers in speaking and coughing conditions. We quantified the number of droplets in flight using laser sheet illumination and UV-light for those that had landed at table height at up to 2m. For human volunteers, expiratory droplets were caught on a microscope slide 5cm from the mouth. Whether manikin or human, wearing a face covering decreased the number of projected droplets by >1000-fold. We estimated that a person standing 2m from someone coughing without a mask is exposed to over 1000 times more respiratory droplets than from someone standing 5 cm away wearing a basic single layer mask. Our results indicate that face coverings show consistent efficacy at blocking respiratory droplets. If aerosol transmission is later determined to be a significant driver of infection, then our findings may overestimate the effectiveness of face coverings.Competing Interest StatementThe authors have declared no competing interest.Funding StatementBandiera is supported by the UK Engineering and Physical Sciences Research Council (EPSRC), grant no. EP/P017134/1. Pavar and Pisetta are supported by the EPSRC grant EP/L016680/1, while Molinari by the EPSRC grant EP/S02431X/1. Otomo`s scholarship is funded by the Japan Student Services Organization. Menolascina is supported by the European Commission (766840) and the EPSRC (EP/S001921/1 and EP/R035350/1), whilst Digard is funded by the UK Biotechnology and Biological Sciences Research Council (BB/P013740/1). Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Research Ethics and Integrity Assessment approved by the Director of Research (Prof. Bernie Mulgrew) of the School of Engineering, the University of EdinburghAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll metadata and raw data are available on Edinburgh DataShare https://datashare.is.ed.ac.uk/